aluates Reports

$ 0.0

Automative

Global Geographic Atrophy Market Research Report 2025

Published Date: February 2025

Report Code: QYRE-Auto-18S10121

Global Geographic Atrophy Market Research Report 2022

BUY CHAPTERS

Global Geographic Atrophy Market Research Report 2025

Code: QYRE-Auto-18S10121

Report

February 2025

Pages:88

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Apellis Pharmaceuticals

IVERIC bio

Alkeus Pharmaceuticals

Stealth Biotherapeutics

Roche

GenSight Biologics

NGM Biopharmaceuticals

Astrazeneca plc

Lineage Cell Therapeutics

Allergan plc

Hemera Biosciences

Allegro Ophthalmics

Gyroscope Therapeutics

Regenerative Patch Technologies

Geographic Atrophy Market Size

The global market for Geographic Atrophy was valued at US$ 1255 million in the year 2024 and is projected to reach a revised size of US$ 1914 million by 2031, growing at a CAGR of 6.3% during the forecast period.

Geographic Atrophy Market

Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) that causes a continuous progressive degeneration of the macula. The condition is characterized by widespread atrophy of the outer retinal tissue, retinal pigment epithelium, and choriocapillaris. It typically starts in the perifoveal region and develops to the fovea over time and causing central scotomas and permanent vision loss. Various drugs and treatments are under evaluation.

According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.

This report aims to provide a comprehensive presentation of the global market for Geographic Atrophy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Geographic Atrophy.

The Geographic Atrophy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Geographic Atrophy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Geographic Atrophy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Geographic Atrophy Market Report

Report Metric	Details
Report Name	Geographic Atrophy Market
Accounted market size in year	US$ 1255 million
Forecasted market size in 2031	US$ 1914 million
CAGR	6.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Above 60 Years Above 75 Years
Segment by Application	Late-stage (Phase III) Phase II Phase I Pre-clinical stage
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Apellis Pharmaceuticals, Iveric Bio, Alkeus Pharmaceuticals, Hemera Biosciences, Allegro Ophthalmics, Stealth BioTherapeutics, Gyroscope Therapeutics, Regenerative Patch Technologies, Roche, Gensight Biologics, NGM Biopharmaceuticals, AstraZeneca, Lineage Cell Therapeutics, Allergan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Geographic Atrophy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Geographic Atrophy Market growing?

Ans: The Geographic Atrophy Market witnessing a CAGR of 6.3% during the forecast period 2025-2031.

What is the Geographic Atrophy Market size in 2031?

Ans: The Geographic Atrophy Market size in 2031 will be US$ 1914 million.

Who are the main players in the Geographic Atrophy Market report?

Ans: The main players in the Geographic Atrophy Market are Apellis Pharmaceuticals, Iveric Bio, Alkeus Pharmaceuticals, Hemera Biosciences, Allegro Ophthalmics, Stealth BioTherapeutics, Gyroscope Therapeutics, Regenerative Patch Technologies, Roche, Gensight Biologics, NGM Biopharmaceuticals, AstraZeneca, Lineage Cell Therapeutics, Allergan

What are the Application segmentation covered in the Geographic Atrophy Market report?

Ans: The Applications covered in the Geographic Atrophy Market report are Late-stage (Phase III), Phase II, Phase I, Pre-clinical stage

What are the Type segmentation covered in the Geographic Atrophy Market report?

Ans: The Types covered in the Geographic Atrophy Market report are Above 60 Years, Above 75 Years

Recommended Reports

Retinal Diseases

Neurodegenerative Disorders

Ophthalmologic Treatments

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Geographic Atrophy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Above 60 Years

1.2.3 Above 75 Years

1.3 Market by Application

1.3.1 Global Geographic Atrophy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Late-stage (Phase III)

1.3.3 Phase II

1.3.4 Phase I

1.3.5 Pre-clinical stage

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Geographic Atrophy Market Perspective (2020-2031)

2.2 Global Geographic Atrophy Growth Trends by Region

2.2.1 Global Geographic Atrophy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Geographic Atrophy Historic Market Size by Region (2020-2025)

2.2.3 Geographic Atrophy Forecasted Market Size by Region (2026-2031)

2.3 Geographic Atrophy Market Dynamics

2.3.1 Geographic Atrophy Industry Trends

2.3.2 Geographic Atrophy Market Drivers

2.3.3 Geographic Atrophy Market Challenges

2.3.4 Geographic Atrophy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Geographic Atrophy Players by Revenue

3.1.1 Global Top Geographic Atrophy Players by Revenue (2020-2025)

3.1.2 Global Geographic Atrophy Revenue Market Share by Players (2020-2025)

3.2 Global Geographic Atrophy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Geographic Atrophy Revenue

3.4 Global Geographic Atrophy Market Concentration Ratio

3.4.1 Global Geographic Atrophy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Geographic Atrophy Revenue in 2024

3.5 Global Key Players of Geographic Atrophy Head office and Area Served

3.6 Global Key Players of Geographic Atrophy, Product and Application

3.7 Global Key Players of Geographic Atrophy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Geographic Atrophy Breakdown Data by Type

4.1 Global Geographic Atrophy Historic Market Size by Type (2020-2025)

4.2 Global Geographic Atrophy Forecasted Market Size by Type (2026-2031)

5 Geographic Atrophy Breakdown Data by Application

5.1 Global Geographic Atrophy Historic Market Size by Application (2020-2025)

5.2 Global Geographic Atrophy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Geographic Atrophy Market Size (2020-2031)

6.2 North America Geographic Atrophy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Geographic Atrophy Market Size by Country (2020-2025)

6.4 North America Geographic Atrophy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Geographic Atrophy Market Size (2020-2031)

7.2 Europe Geographic Atrophy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Geographic Atrophy Market Size by Country (2020-2025)

7.4 Europe Geographic Atrophy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Geographic Atrophy Market Size (2020-2031)

8.2 Asia-Pacific Geographic Atrophy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Geographic Atrophy Market Size by Region (2020-2025)

8.4 Asia-Pacific Geographic Atrophy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Geographic Atrophy Market Size (2020-2031)

9.2 Latin America Geographic Atrophy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Geographic Atrophy Market Size by Country (2020-2025)

9.4 Latin America Geographic Atrophy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Geographic Atrophy Market Size (2020-2031)

10.2 Middle East & Africa Geographic Atrophy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Geographic Atrophy Market Size by Country (2020-2025)

10.4 Middle East & Africa Geographic Atrophy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Apellis Pharmaceuticals

11.1.1 Apellis Pharmaceuticals Company Details

11.1.2 Apellis Pharmaceuticals Business Overview

11.1.3 Apellis Pharmaceuticals Geographic Atrophy Introduction

11.1.4 Apellis Pharmaceuticals Revenue in Geographic Atrophy Business (2020-2025)

11.1.5 Apellis Pharmaceuticals Recent Development

11.2 Iveric Bio

11.2.1 Iveric Bio Company Details

11.2.2 Iveric Bio Business Overview

11.2.3 Iveric Bio Geographic Atrophy Introduction

11.2.4 Iveric Bio Revenue in Geographic Atrophy Business (2020-2025)

11.2.5 Iveric Bio Recent Development

11.3 Alkeus Pharmaceuticals

11.3.1 Alkeus Pharmaceuticals Company Details

11.3.2 Alkeus Pharmaceuticals Business Overview

11.3.3 Alkeus Pharmaceuticals Geographic Atrophy Introduction

11.3.4 Alkeus Pharmaceuticals Revenue in Geographic Atrophy Business (2020-2025)

11.3.5 Alkeus Pharmaceuticals Recent Development

11.4 Hemera Biosciences

11.4.1 Hemera Biosciences Company Details

11.4.2 Hemera Biosciences Business Overview

11.4.3 Hemera Biosciences Geographic Atrophy Introduction

11.4.4 Hemera Biosciences Revenue in Geographic Atrophy Business (2020-2025)

11.4.5 Hemera Biosciences Recent Development

11.5 Allegro Ophthalmics

11.5.1 Allegro Ophthalmics Company Details

11.5.2 Allegro Ophthalmics Business Overview

11.5.3 Allegro Ophthalmics Geographic Atrophy Introduction

11.5.4 Allegro Ophthalmics Revenue in Geographic Atrophy Business (2020-2025)

11.5.5 Allegro Ophthalmics Recent Development

11.6 Stealth BioTherapeutics

11.6.1 Stealth BioTherapeutics Company Details

11.6.2 Stealth BioTherapeutics Business Overview

11.6.3 Stealth BioTherapeutics Geographic Atrophy Introduction

11.6.4 Stealth BioTherapeutics Revenue in Geographic Atrophy Business (2020-2025)

11.6.5 Stealth BioTherapeutics Recent Development

11.7 Gyroscope Therapeutics

11.7.1 Gyroscope Therapeutics Company Details

11.7.2 Gyroscope Therapeutics Business Overview

11.7.3 Gyroscope Therapeutics Geographic Atrophy Introduction

11.7.4 Gyroscope Therapeutics Revenue in Geographic Atrophy Business (2020-2025)

11.7.5 Gyroscope Therapeutics Recent Development

11.8 Regenerative Patch Technologies

11.8.1 Regenerative Patch Technologies Company Details

11.8.2 Regenerative Patch Technologies Business Overview

11.8.3 Regenerative Patch Technologies Geographic Atrophy Introduction

11.8.4 Regenerative Patch Technologies Revenue in Geographic Atrophy Business (2020-2025)

11.8.5 Regenerative Patch Technologies Recent Development

11.9 Roche

11.9.1 Roche Company Details

11.9.2 Roche Business Overview

11.9.3 Roche Geographic Atrophy Introduction

11.9.4 Roche Revenue in Geographic Atrophy Business (2020-2025)

11.9.5 Roche Recent Development

11.10 Gensight Biologics

11.10.1 Gensight Biologics Company Details

11.10.2 Gensight Biologics Business Overview

11.10.3 Gensight Biologics Geographic Atrophy Introduction

11.10.4 Gensight Biologics Revenue in Geographic Atrophy Business (2020-2025)

11.10.5 Gensight Biologics Recent Development

11.11 NGM Biopharmaceuticals

11.11.1 NGM Biopharmaceuticals Company Details

11.11.2 NGM Biopharmaceuticals Business Overview

11.11.3 NGM Biopharmaceuticals Geographic Atrophy Introduction

11.11.4 NGM Biopharmaceuticals Revenue in Geographic Atrophy Business (2020-2025)

11.11.5 NGM Biopharmaceuticals Recent Development

11.12 AstraZeneca

11.12.1 AstraZeneca Company Details

11.12.2 AstraZeneca Business Overview

11.12.3 AstraZeneca Geographic Atrophy Introduction

11.12.4 AstraZeneca Revenue in Geographic Atrophy Business (2020-2025)

11.12.5 AstraZeneca Recent Development

11.13 Lineage Cell Therapeutics

11.13.1 Lineage Cell Therapeutics Company Details

11.13.2 Lineage Cell Therapeutics Business Overview

11.13.3 Lineage Cell Therapeutics Geographic Atrophy Introduction

11.13.4 Lineage Cell Therapeutics Revenue in Geographic Atrophy Business (2020-2025)

11.13.5 Lineage Cell Therapeutics Recent Development

11.14 Allergan

11.14.1 Allergan Company Details

11.14.2 Allergan Business Overview

11.14.3 Allergan Geographic Atrophy Introduction

11.14.4 Allergan Revenue in Geographic Atrophy Business (2020-2025)

11.14.5 Allergan Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Apellis Pharmaceuticals

IVERIC bio

Alkeus Pharmaceuticals

Stealth Biotherapeutics

Roche

GenSight Biologics

NGM Biopharmaceuticals

Astrazeneca plc

Lineage Cell Therapeutics

Allergan plc

Hemera Biosciences

Allegro Ophthalmics

Gyroscope Therapeutics

Regenerative Patch Technologies

List of Tables

Table 1. Global Geographic Atrophy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Above 60 Years

Table 3. Key Players of Above 75 Years

Table 4. Global Geographic Atrophy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Geographic Atrophy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Geographic Atrophy Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Geographic Atrophy Market Share by Region (2020-2025)

Table 8. Global Geographic Atrophy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Geographic Atrophy Market Share by Region (2026-2031)

Table 10. Geographic Atrophy Market Trends

Table 11. Geographic Atrophy Market Drivers

Table 12. Geographic Atrophy Market Challenges

Table 13. Geographic Atrophy Market Restraints

Table 14. Global Geographic Atrophy Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Geographic Atrophy Market Share by Players (2020-2025)

Table 16. Global Top Geographic Atrophy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geographic Atrophy as of 2024)

Table 17. Ranking of Global Top Geographic Atrophy Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Geographic Atrophy Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Geographic Atrophy, Headquarters and Area Served

Table 20. Global Key Players of Geographic Atrophy, Product and Application

Table 21. Global Key Players of Geographic Atrophy, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Geographic Atrophy Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Geographic Atrophy Revenue Market Share by Type (2020-2025)

Table 25. Global Geographic Atrophy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Geographic Atrophy Revenue Market Share by Type (2026-2031)

Table 27. Global Geographic Atrophy Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Geographic Atrophy Revenue Market Share by Application (2020-2025)

Table 29. Global Geographic Atrophy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Geographic Atrophy Revenue Market Share by Application (2026-2031)

Table 31. North America Geographic Atrophy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Geographic Atrophy Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Geographic Atrophy Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Geographic Atrophy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Geographic Atrophy Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Geographic Atrophy Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Geographic Atrophy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Geographic Atrophy Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Geographic Atrophy Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Geographic Atrophy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Geographic Atrophy Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Geographic Atrophy Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Geographic Atrophy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Geographic Atrophy Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Geographic Atrophy Market Size by Country (2026-2031) & (US$ Million)

Table 46. Apellis Pharmaceuticals Company Details

Table 47. Apellis Pharmaceuticals Business Overview

Table 48. Apellis Pharmaceuticals Geographic Atrophy Product

Table 49. Apellis Pharmaceuticals Revenue in Geographic Atrophy Business (2020-2025) & (US$ Million)

Table 50. Apellis Pharmaceuticals Recent Development

Table 51. Iveric Bio Company Details

Table 52. Iveric Bio Business Overview

Table 53. Iveric Bio Geographic Atrophy Product

Table 54. Iveric Bio Revenue in Geographic Atrophy Business (2020-2025) & (US$ Million)

Table 55. Iveric Bio Recent Development

Table 56. Alkeus Pharmaceuticals Company Details

Table 57. Alkeus Pharmaceuticals Business Overview

Table 58. Alkeus Pharmaceuticals Geographic Atrophy Product

Table 59. Alkeus Pharmaceuticals Revenue in Geographic Atrophy Business (2020-2025) & (US$ Million)

Table 60. Alkeus Pharmaceuticals Recent Development

Table 61. Hemera Biosciences Company Details

Table 62. Hemera Biosciences Business Overview

Table 63. Hemera Biosciences Geographic Atrophy Product

Table 64. Hemera Biosciences Revenue in Geographic Atrophy Business (2020-2025) & (US$ Million)

Table 65. Hemera Biosciences Recent Development

Table 66. Allegro Ophthalmics Company Details

Table 67. Allegro Ophthalmics Business Overview

Table 68. Allegro Ophthalmics Geographic Atrophy Product

Table 69. Allegro Ophthalmics Revenue in Geographic Atrophy Business (2020-2025) & (US$ Million)

Table 70. Allegro Ophthalmics Recent Development

Table 71. Stealth BioTherapeutics Company Details

Table 72. Stealth BioTherapeutics Business Overview

Table 73. Stealth BioTherapeutics Geographic Atrophy Product

Table 74. Stealth BioTherapeutics Revenue in Geographic Atrophy Business (2020-2025) & (US$ Million)

Table 75. Stealth BioTherapeutics Recent Development

Table 76. Gyroscope Therapeutics Company Details

Table 77. Gyroscope Therapeutics Business Overview

Table 78. Gyroscope Therapeutics Geographic Atrophy Product

Table 79. Gyroscope Therapeutics Revenue in Geographic Atrophy Business (2020-2025) & (US$ Million)

Table 80. Gyroscope Therapeutics Recent Development

Table 81. Regenerative Patch Technologies Company Details

Table 82. Regenerative Patch Technologies Business Overview

Table 83. Regenerative Patch Technologies Geographic Atrophy Product

Table 84. Regenerative Patch Technologies Revenue in Geographic Atrophy Business (2020-2025) & (US$ Million)

Table 85. Regenerative Patch Technologies Recent Development

Table 86. Roche Company Details

Table 87. Roche Business Overview

Table 88. Roche Geographic Atrophy Product

Table 89. Roche Revenue in Geographic Atrophy Business (2020-2025) & (US$ Million)

Table 90. Roche Recent Development

Table 91. Gensight Biologics Company Details

Table 92. Gensight Biologics Business Overview

Table 93. Gensight Biologics Geographic Atrophy Product

Table 94. Gensight Biologics Revenue in Geographic Atrophy Business (2020-2025) & (US$ Million)

Table 95. Gensight Biologics Recent Development

Table 96. NGM Biopharmaceuticals Company Details

Table 97. NGM Biopharmaceuticals Business Overview

Table 98. NGM Biopharmaceuticals Geographic Atrophy Product

Table 99. NGM Biopharmaceuticals Revenue in Geographic Atrophy Business (2020-2025) & (US$ Million)

Table 100. NGM Biopharmaceuticals Recent Development

Table 101. AstraZeneca Company Details

Table 102. AstraZeneca Business Overview

Table 103. AstraZeneca Geographic Atrophy Product

Table 104. AstraZeneca Revenue in Geographic Atrophy Business (2020-2025) & (US$ Million)

Table 105. AstraZeneca Recent Development

Table 106. Lineage Cell Therapeutics Company Details

Table 107. Lineage Cell Therapeutics Business Overview

Table 108. Lineage Cell Therapeutics Geographic Atrophy Product

Table 109. Lineage Cell Therapeutics Revenue in Geographic Atrophy Business (2020-2025) & (US$ Million)

Table 110. Lineage Cell Therapeutics Recent Development

Table 111. Allergan Company Details

Table 112. Allergan Business Overview

Table 113. Allergan Geographic Atrophy Product

Table 114. Allergan Revenue in Geographic Atrophy Business (2020-2025) & (US$ Million)

Table 115. Allergan Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

Table 119. Authors List of This Report

List of Figures

Figure 1. Geographic Atrophy Picture

Figure 2. Global Geographic Atrophy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Geographic Atrophy Market Share by Type: 2024 VS 2031

Figure 4. Above 60 Years Features

Figure 5. Above 75 Years Features

Figure 6. Global Geographic Atrophy Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Geographic Atrophy Market Share by Application: 2024 VS 2031

Figure 8. Late-stage (Phase III) Case Studies

Figure 9. Phase II Case Studies

Figure 10. Phase I Case Studies

Figure 11. Pre-clinical stage Case Studies

Figure 12. Geographic Atrophy Report Years Considered

Figure 13. Global Geographic Atrophy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Geographic Atrophy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Geographic Atrophy Market Share by Region: 2024 VS 2031

Figure 16. Global Geographic Atrophy Market Share by Players in 2024

Figure 17. Global Top Geographic Atrophy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geographic Atrophy as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Geographic Atrophy Revenue in 2024

Figure 19. North America Geographic Atrophy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Geographic Atrophy Market Share by Country (2020-2031)

Figure 21. United States Geographic Atrophy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Geographic Atrophy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Geographic Atrophy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Geographic Atrophy Market Share by Country (2020-2031)

Figure 25. Germany Geographic Atrophy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Geographic Atrophy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Geographic Atrophy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Geographic Atrophy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Geographic Atrophy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Geographic Atrophy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Geographic Atrophy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Geographic Atrophy Market Share by Region (2020-2031)

Figure 33. China Geographic Atrophy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Geographic Atrophy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Geographic Atrophy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Geographic Atrophy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Geographic Atrophy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Geographic Atrophy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Geographic Atrophy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Geographic Atrophy Market Share by Country (2020-2031)

Figure 41. Mexico Geographic Atrophy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Geographic Atrophy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Geographic Atrophy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Geographic Atrophy Market Share by Country (2020-2031)

Figure 45. Turkey Geographic Atrophy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Geographic Atrophy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Geographic Atrophy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Apellis Pharmaceuticals Revenue Growth Rate in Geographic Atrophy Business (2020-2025)

Figure 49. Iveric Bio Revenue Growth Rate in Geographic Atrophy Business (2020-2025)

Figure 50. Alkeus Pharmaceuticals Revenue Growth Rate in Geographic Atrophy Business (2020-2025)

Figure 51. Hemera Biosciences Revenue Growth Rate in Geographic Atrophy Business (2020-2025)

Figure 52. Allegro Ophthalmics Revenue Growth Rate in Geographic Atrophy Business (2020-2025)

Figure 53. Stealth BioTherapeutics Revenue Growth Rate in Geographic Atrophy Business (2020-2025)

Figure 54. Gyroscope Therapeutics Revenue Growth Rate in Geographic Atrophy Business (2020-2025)

Figure 55. Regenerative Patch Technologies Revenue Growth Rate in Geographic Atrophy Business (2020-2025)

Figure 56. Roche Revenue Growth Rate in Geographic Atrophy Business (2020-2025)

Figure 57. Gensight Biologics Revenue Growth Rate in Geographic Atrophy Business (2020-2025)

Figure 58. NGM Biopharmaceuticals Revenue Growth Rate in Geographic Atrophy Business (2020-2025)

Figure 59. AstraZeneca Revenue Growth Rate in Geographic Atrophy Business (2020-2025)

Figure 60. Lineage Cell Therapeutics Revenue Growth Rate in Geographic Atrophy Business (2020-2025)

Figure 61. Allergan Revenue Growth Rate in Geographic Atrophy Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Macular Degeneration Treatment Market Research Report 2024

Global Macular Degeneration AMD and Other Retinal Diseases Market Research Report 2024

Global Ophthalmology Disorders Drug Market Insights Forecast to 2030

Global Macular Edema and Macular Degeneration Market Research Report 2025

Global Ophthalmology for Age related Macular Degeneration Diseases Market Research Report 2024

Geographic Atrophy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Retinitis Pigmentosa Retinitis Market Insights Forecast to 2030

Global Retinal Disorders Treatment Market Research Report 2024

Global Cone rod Dystrophy Treatment Market Research Report 2025

Choroideremia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diabetic Retinopathy DR Artificial Intelligence Screening System Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions